Want to join the conversation?
$ESRX said its 2015 prescription drug spending growth rate was 5.2%, roughly half of 2014, helped by greater client adoption of its solutions and specialized pharmacy care for patients. Total drug spending is forecast to rise 6-8% annually between 2016 and 2018. Specialty spending is forecast to grow about 17% annually over next 3 years.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?